Description

Pantoprazol Lyophilisate for Solution for Infusions 40 mg. Vial №1

Ingredients:

Each vial contains Pantoprazole sodium sesquihydrate equivalent to Pantoprazole 40 mg.

Dosage:

The recommended dosage is 40 mg once daily via intravenous infusion over 15 minutes.

Indications:

Pantoprazol lyophilisate is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and pathological hypersecretory conditions.

Contraindications:

Do not use in patients with known hypersensitivity to Pantoprazole or substituted benzimidazoles.

Directions:

Administer as a slow intravenous infusion. Do not mix with other medications or solutions.

Scientific Evidence:

Pantoprazole, a proton pump inhibitor, works by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a reduction in gastric acid secretion. Clinical studies have demonstrated the efficacy of Pantoprazole in the treatment of acid-related disorders.

Research published in the Journal of Gastroenterology and Hepatology showed that Pantoprazole was effective in maintaining remission in patients with erosive esophagitis. The study highlighted the superior efficacy of Pantoprazole compared to placebo in preventing relapse.

Additional Information:

• Storage: Store below 25°C. Protect from light.
• Manufacturer: This product is manufactured by a reputable pharmaceutical company under strict quality standards.